Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder

Clinical trial NCT00461292 · COMPLETED

Trial details

NCT number: NCT00461292
Sponsor: Allergan
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Overactive Bladder

Start date: 2007-05-01
Primary completion: 2010-03-01
Enrollment: 275

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.